Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms. — CFSMEATLAS
E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedMachine draft
Standard · 3 min
Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms.
Jason, L A, Taylor, R R, Kennedy, C L · Psychosomatic medicine · 2000 · DOI
Quick Summary
This study looked at how often people with ME/CFS (chronic fatigue syndrome) also have fibromyalgia or chemical sensitivities, and how these conditions affect daily functioning. Researchers interviewed nearly 19,000 people in Chicago and then examined those with CFS-like symptoms in more detail. They found that people with multiple conditions experienced worse fatigue and disability than those with just one condition.
Why It Matters
This study demonstrates that ME/CFS frequently co-occurs with other debilitating conditions like fibromyalgia and multiple chemical sensitivities, and that having multiple diagnoses substantially worsens fatigue and disability. Understanding these comorbidity patterns helps clinicians recognize overlapping symptom presentations and may improve patient care and resource allocation.
Observed Findings
Among 32 individuals with CFS, 40.6% met criteria for multiple chemical sensitivities and 15.6% met criteria for fibromyalgia.
Individuals with MCS or multiple diagnoses reported significantly more physical fatigue than those with no diagnosis.
Individuals with multiple diagnoses reported greater mental fatigue and were less likely to be employed than those with single or no diagnoses.
All individuals with CFS, MCS, FM, or multiple diagnoses reported greater disability in physical, occupational, and social functioning compared to controls.
Comorbidity rates in this community sample were notably lower than rates reported in prior clinical samples.
Inferred Conclusions
Comorbidity among CFS, FM, and MCS is common and associated with increased symptom severity and functional impairment.
Individuals with multiple concurrent diagnoses experience compounded disability and fatigue beyond that of single-diagnosis groups.
Differences in sampling methodology (community-based versus clinical) may explain varying comorbidity rates across studies.
These three conditions represent a spectrum of illness with varying functional impact that warrants individualized assessment.
Remaining Questions
What This Study Does Not Prove
This cross-sectional design cannot establish causality or temporal relationships between conditions—it only shows associations at a single point in time. The study cannot determine whether one condition causes another, whether they share a common biological mechanism, or whether the lower comorbidity rates reflect true differences in disease occurrence versus differences in how cases were identified and defined. The relatively small final sample (32 CFS cases) limits generalizability to broader populations.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
What is the temporal relationship between CFS, FM, and MCS—do these conditions develop sequentially or simultaneously, and does one increase risk for the others?
What biological mechanisms might underlie the observed comorbidity patterns?
Why were comorbidity rates substantially lower in this community sample compared to clinical samples, and how does this affect interpretation across studies?
How do specific symptom clusters in individuals with multiple diagnoses differ from single-diagnosis presentations, and does this affect treatment outcomes?